StepStone Group Inc.

Fundamentals3.0
Price Action5.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Persistent losses
  • Negative equity
  • Positive cashflow

AI
AI Summary

5.0

STEP's investment case has shifted from a growth optionality story to a binary execution and capital‑allocation test: investors should watch whether management can convert fee growth into sustained gross‑margin recovery, consistent FCF-to-operating‑profit within 12–24 months and restore tangible equity (failure risks continued re-rating and a break below ~$43).

Execution
BalanceSheet
Watchlist‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

3.0

Key Financial Insights:

  • Persistent losses
  • Negative equity
  • Positive cashflow

Step Technologies shows adequate near-term liquidity and positive free cash flow but is burdened by persistent operating losses, negative recent shareholders' equity and high leverage that make its valuation dependent on hoped-for growth rather than current profitability.

HighLeverage
CashRunway

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Rapid sell‑off
  • Short‑term support
  • Resistance cap

STEP is in a sharp downtrend over the last month, plunging from the mid‑70s to the mid‑40s with a small bounce off $43.33 suggesting short‑term support near $43–$44 but significant downside risk if that level breaks.

bearish
watchlist
Support Level: $43.00–$44.00
Resistance Level: $48.00–$50.00

>35% drop from ~$69.39 to ~$46.73 over the last month indicating strong negative momentum

Sentiment & News

6.0

Key News Insights:

  • Share repurchase
  • Distribution expansion
  • Senior promotions

StepStone announced a $100M buyback, senior promotions and partner hires, expanded retail distribution and led an oversubscribed fund closing above $1B, while earning PERE awards and attracting a notable shareholder increase, with an unrelated FDA headline conflated in coverage.

Buyback
PrivateMarkets

The buyback, institutional recognition and distribution moves should support valuation and organic growth, while senior hires and investor interest signal momentum for STEP shares